BLOOD COAGULATION PROTEIN CONJUGATES
    3.
    发明公开
    BLOOD COAGULATION PROTEIN CONJUGATES 有权
    血液凝固蛋白缀合物

    公开(公告)号:EP2459224A2

    公开(公告)日:2012-06-06

    申请号:EP10738119.6

    申请日:2010-07-26

    IPC分类号: A61K47/48

    摘要: The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a blood coagulation protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer. In one embodiment of the invention the conjugation is carried out in the presence of the nucleophilic catalyst aniline. In addition the generated oxime linkage can be stabilized by reduction with NaCNBH
    3 to form an alkoxyamine linkage.

    摘要翻译: 本发明涉及使水溶性聚合物与血液凝固蛋白的氧化碳水化合物部分缀合的材料和方法,包括使氧化碳水化合物部分与活化的水溶性聚合物在允许缀合的条件下接触。 更具体地说,本发明涉及上述材料和方法,其中水溶性聚合物含有活性氨氧基,并且其中在水溶性聚合物上的氧化碳水化合物部分和活性氨氧基之间形成肟键。 在本发明的一个实施方案中,缀合在亲核催化剂苯胺存在下进行。 另外,生成的肟键可以通过用NaCNBH 3还原形成烷氧基胺键来稳定。

    POLYMER-VON WILLEBRAND FACTOR-CONJUGATES
    4.
    发明公开
    POLYMER-VON WILLEBRAND FACTOR-CONJUGATES 有权
    聚合物血管性血友病因子结合物

    公开(公告)号:EP1835938A2

    公开(公告)日:2007-09-26

    申请号:EP05855442.9

    申请日:2005-12-23

    IPC分类号: A61K47/48

    摘要: The present invention relates to a proteinaceous construc (also designated as polymer-VWF-conjugate) comprising plasmatic and/or recombinant von Willebrand factor (VWF), said VWF being bound to at least one physiologically acceptable polymer molecule, as well as to a complex said proteinaceous construc and at least one factor VIII (FVIII) protein. The physiologically acceptable polymer molecule can be, for instance, polyethylene glycol (PEG) or polysialic acid (PSA). Further the present invention relates to methods for prolonging the in vivo-half-life of VWF or FVIII in the blood of a mammal having a bleeding disorder associated with functional defects of or deficiencies of at least one of FVIII or VWF.

    NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE
    9.
    发明公开
    NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE 审中-公开
    NUKLEOPHILE KATALYSATORENFÜROXIM-VERBINDUNG

    公开(公告)号:EP2598172A1

    公开(公告)日:2013-06-05

    申请号:EP11741727.9

    申请日:2011-07-29

    IPC分类号: A61K47/48

    CPC分类号: A61K47/61 A61K47/60

    摘要: The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a therapeutic protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime or hydrazone linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer, and wherein the conjugation is carried out in the presence of a nucleophilic catalyst.

    摘要翻译: 本发明涉及将水溶性聚合物与治疗性蛋白质的氧化碳水化合物部分缀合的材料和方法,包括在允许缀合的条件下使氧化的碳水化合物部分与活化的水溶性聚合物接触。 更具体地说,本发明涉及上述材料和方法,其中水溶性聚合物含有活性氨基氧基,其中在水溶性聚合物上的氧化碳水化合物部分和活性氨基氧基之间形成肟或腙键,其中 共轭在亲核催化剂存在下进行。

    DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES
    10.
    发明公开
    DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES 审中-公开
    AN水可溶聚合物证明修饰多肽结合抗体

    公开(公告)号:EP2435833A1

    公开(公告)日:2012-04-04

    申请号:EP10727212.2

    申请日:2010-05-25

    IPC分类号: G01N33/68

    CPC分类号: G01N33/6854

    摘要: The present invention provides analytical methods for detecting anti- polymer antibody in an individual. The methods involve contacting a sample from the individual with a water soluble polymer-modified carrier and detecting binding of antibody to the water soluble polymer on the water soluble polymer-modified carrier wherein binding is indicative of the presence of antibody to the water polymer-modified polypeptide. Antibody may be detected to water soluble polymers such as polyethylene glycol, polysialic acid, dextran, hydroxyalkyl starch, or hydroxyethyl starch. When antibody to the water soluble polymer polyethylene glycol is to be detected, the carrier is modified with a non-linear polyethylene glycol derivative.